Market Cap 5.74B
Revenue (ttm) 1.83B
Net Income (ttm) 2.79M
EPS (ttm) N/A
PE Ratio 206.58
Forward PE 173.16
Profit Margin 0.15%
Debt to Equity Ratio 0.91
Volume 479,238
Avg Vol 704,834
Day's Range N/A - N/A
Shares Out 77.15M
Stochastic %K 7%
Beta 1.58
Analysts Strong Sell
Price Target $80.67

Company Profile

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells co...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 310 478 7808
Fax: 310 445 2980
Address:
1510 Cotner Avenue, Los Angeles, United States
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:24 AM
$RDNT is currently trading at $73.46, significantly below its 30-day moving average (MA30) of $77.54 and 50-day moving average (MA50) of $76.52, indicating a bearish trend. The RSI of 26.96 suggests that the stock is oversold, which could lead to a potential reversal. However, the stock remains within a 60-day high of $84.71 and a low of $67.93, indicating a volatile range. Given the current metrics, a suggested entry point could be around $72.50, just above the recent low. A stop loss could be set at $67.50 to manage risk. If the stock shows signs of recovery, targets could be set at $76.00 (near MA50) and $78.00 (near MA30), taking advantage of the potential upward movement. This trade plan capitalizes on the oversold condition indicated by the RSI while considering the proximity to recent lows and moving averages. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 8:31 PM
Barclays has updated their rating for RadNet ( $RDNT ) to Overweight with a price target of 86.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:30 AM
$RDNT is currently trading at $78.5, showing a neutral market context with an RSI of 44.49, indicating that the stock is neither overbought nor oversold. The price is above the 30-day moving average (MA30) of $77.82 and significantly above the 50-day moving average (MA50) of $76.42, suggesting a bullish short-term trend. However, the RSI indicates potential weakness, as it is below the neutral level of 50. Given the 60-day high of $84.71 and low of $66.24, the stock has room to move upward but is currently closer to the lower end of this range. Suggested entry is at $79.00, with a stop loss set at $76.50 to manage risk. Target 1 is $82.00, aligning with resistance near the recent highs, and Target 2 is $84.00, near the 60-day high. Monitor for any changes in RSI and price action for adjustments. https://privateprofiteers.com
0 · Reply
erevnon
erevnon Nov. 12 at 6:47 PM
Truist Securities maintains RadNet $RDNT at Buy and raises the price target from $81 to $90 https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 6:13 PM
Truist Securities updates rating for RadNet ( $RDNT ) to Buy, target set at 81 → 90.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:06 AM
$RDNT is currently trading at $78.5, showing a neutral market context with an RSI of 44.49, indicating that the stock is neither overbought nor oversold. The price is above the 30-day moving average (MA30) of $77.82 and significantly above the 50-day moving average (MA50) of $76.42, suggesting a bullish short-term trend. However, the RSI indicates potential weakness, as it is below the neutral level of 50. Given the 60-day high of $84.71 and low of $66.24, the stock has room to move upward but is currently closer to the lower end of this range. Suggested entry is at $79.00, with a stop loss set at $76.50 to manage risk. Target 1 is $82.00, aligning with resistance near the recent highs, and Target 2 is $84.00, near the 60-day high. Monitor for any changes in RSI and price action for adjustments. https://privateprofiteers.com
0 · Reply
Knife_catcher101
Knife_catcher101 Nov. 11 at 9:24 PM
$RDNT what the fuck was that
0 · Reply
PatrickandFrankie
PatrickandFrankie Nov. 11 at 12:12 PM
$RDNT great report! Glad I kept my shares after ICAD buyout.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 6 at 7:50 PM
$RDNT Share Price: $79.00 Contract Selected: Mar 20, 2026 $80 Calls Buy Zone: $7.99 – $9.87 Target Zone: $13.18 – $16.10 Potential Upside: 56% ROI Time to Expiration: 133 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 30 at 12:08 PM
$HOLX $RDNT $VREX NASDAQ: RADX Chicago based radiation oncologist reviewing Radiopharm Theranostics brain imaging agent Pivalate. https://www.youtube.com/watch?v=d1lhPMFcrvY $AWRE
0 · Reply
Latest News on RDNT
RadNet, Inc. (RDNT) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 3:11 PM EST - 4 days ago

RadNet, Inc. (RDNT) Q3 2025 Earnings Call Transcript


RadNet to Host Investor Day on November 11, 2025

Oct 21, 2025, 6:00 AM EDT - 24 days ago

RadNet to Host Investor Day on November 11, 2025


RadNet, Inc. (RDNT) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 12:50 PM EDT - 3 months ago

RadNet, Inc. (RDNT) Q2 2025 Earnings Call Transcript


RadNet, Inc. (RDNT) Q1 2025 Earnings Call Transcript

May 12, 2025, 3:29 PM EDT - 6 months ago

RadNet, Inc. (RDNT) Q1 2025 Earnings Call Transcript


RadNet, Inc. (RDNT) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 1:12 PM EST - 9 months ago

RadNet, Inc. (RDNT) Q4 2024 Earnings Call Transcript


Top 3 Health Care Stocks That Could Blast Off This Quarter

Jan 22, 2025, 6:46 AM EST - 10 months ago

Top 3 Health Care Stocks That Could Blast Off This Quarter

VERA VKTX


RadNet, Inc. (RDNT) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 10:34 PM EST - 1 year ago

RadNet, Inc. (RDNT) Q3 2024 Earnings Call Transcript


PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:24 AM
$RDNT is currently trading at $73.46, significantly below its 30-day moving average (MA30) of $77.54 and 50-day moving average (MA50) of $76.52, indicating a bearish trend. The RSI of 26.96 suggests that the stock is oversold, which could lead to a potential reversal. However, the stock remains within a 60-day high of $84.71 and a low of $67.93, indicating a volatile range. Given the current metrics, a suggested entry point could be around $72.50, just above the recent low. A stop loss could be set at $67.50 to manage risk. If the stock shows signs of recovery, targets could be set at $76.00 (near MA50) and $78.00 (near MA30), taking advantage of the potential upward movement. This trade plan capitalizes on the oversold condition indicated by the RSI while considering the proximity to recent lows and moving averages. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 8:31 PM
Barclays has updated their rating for RadNet ( $RDNT ) to Overweight with a price target of 86.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:30 AM
$RDNT is currently trading at $78.5, showing a neutral market context with an RSI of 44.49, indicating that the stock is neither overbought nor oversold. The price is above the 30-day moving average (MA30) of $77.82 and significantly above the 50-day moving average (MA50) of $76.42, suggesting a bullish short-term trend. However, the RSI indicates potential weakness, as it is below the neutral level of 50. Given the 60-day high of $84.71 and low of $66.24, the stock has room to move upward but is currently closer to the lower end of this range. Suggested entry is at $79.00, with a stop loss set at $76.50 to manage risk. Target 1 is $82.00, aligning with resistance near the recent highs, and Target 2 is $84.00, near the 60-day high. Monitor for any changes in RSI and price action for adjustments. https://privateprofiteers.com
0 · Reply
erevnon
erevnon Nov. 12 at 6:47 PM
Truist Securities maintains RadNet $RDNT at Buy and raises the price target from $81 to $90 https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 6:13 PM
Truist Securities updates rating for RadNet ( $RDNT ) to Buy, target set at 81 → 90.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:06 AM
$RDNT is currently trading at $78.5, showing a neutral market context with an RSI of 44.49, indicating that the stock is neither overbought nor oversold. The price is above the 30-day moving average (MA30) of $77.82 and significantly above the 50-day moving average (MA50) of $76.42, suggesting a bullish short-term trend. However, the RSI indicates potential weakness, as it is below the neutral level of 50. Given the 60-day high of $84.71 and low of $66.24, the stock has room to move upward but is currently closer to the lower end of this range. Suggested entry is at $79.00, with a stop loss set at $76.50 to manage risk. Target 1 is $82.00, aligning with resistance near the recent highs, and Target 2 is $84.00, near the 60-day high. Monitor for any changes in RSI and price action for adjustments. https://privateprofiteers.com
0 · Reply
Knife_catcher101
Knife_catcher101 Nov. 11 at 9:24 PM
$RDNT what the fuck was that
0 · Reply
PatrickandFrankie
PatrickandFrankie Nov. 11 at 12:12 PM
$RDNT great report! Glad I kept my shares after ICAD buyout.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 6 at 7:50 PM
$RDNT Share Price: $79.00 Contract Selected: Mar 20, 2026 $80 Calls Buy Zone: $7.99 – $9.87 Target Zone: $13.18 – $16.10 Potential Upside: 56% ROI Time to Expiration: 133 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 30 at 12:08 PM
$HOLX $RDNT $VREX NASDAQ: RADX Chicago based radiation oncologist reviewing Radiopharm Theranostics brain imaging agent Pivalate. https://www.youtube.com/watch?v=d1lhPMFcrvY $AWRE
0 · Reply
NetworkNewsWire
NetworkNewsWire Oct. 23 at 1:19 PM
Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market $IZO.CN $IZOZF $NVDA $BFLY $LNTH $RDNT https://ibn.fm/Rus4S
0 · Reply
Estimize
Estimize Oct. 2 at 11:03 AM
Wall St is expecting 0.22 EPS for $RDNT Q3 [Reporting 11/05 AMC] http://www.estimize.com/intro/rdnt?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Sep. 18 at 11:03 AM
Wall St is expecting 0.22 EPS for $RDNT Q3 [Reporting 11/05 AMC] http://www.estimize.com/intro/rdnt?chart=historical&metric_name=eps&utm_co
0 · Reply
Jonjon1234
Jonjon1234 Sep. 17 at 8:16 PM
$RDNT Just had some diagnostics performed at a Radnet facility. 5 star review. Not selling shares anytime soon.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Sep. 8 at 4:52 PM
$RDNT RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025
0 · Reply
IN0V8
IN0V8 Sep. 4 at 3:47 PM
$RDNT Opportunity Truist Securities raises target price to $81 from $74
1 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Sep. 3 at 2:31 PM
$RDNT Barclays Maintains Overweight on RadNet, Raises Price Target to $79
0 · Reply
JarvisFlow
JarvisFlow Sep. 3 at 2:20 PM
Barclays has adjusted their stance on RadNet ( $RDNT ), setting the rating to Overweight with a target price of 60 → 79.
0 · Reply
JarvisFlow
JarvisFlow Sep. 3 at 1:00 PM
Truist Securities has updated their rating for RadNet ( $RDNT ) to Buy with a price target of 81.
0 · Reply
MitchOnX
MitchOnX Aug. 30 at 1:39 PM
$RDNT $RDNT Radnet Inc - 60 Second Analysis - August 30, 2025 #RDNT #RADNETIN... https://youtu.be/LPJBDNfv1Ms?si=4fjvd6yH05YRgqAl via @YouTube
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Aug. 30 at 12:05 PM
$RDNT big move happening here. prob looking back at ath
1 · Reply
Joeymoey
Joeymoey Aug. 28 at 10:38 PM
0 · Reply